Form 483

NOVA LABORATORIES LIMITED Form 483, 2020-02-25

FDA issued a Form 483 to NOVA LABORATORIES LIMITED on 2020-02-25 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

NOVA LABORATORIES LIMITED · Wigston, United Kingdom · Issued February 25, 2020

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

25 Feb 2020
21 CFR 211.160(b)(3)

Acceptance of drug products

Cited by Christopher R Czajka

25 Feb 2020
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Christopher R Czajka

25 Feb 2020
21 CFR 211.67(c)

Cleaning/maintenance records not kept

Cited by Christopher R Czajka

25 Feb 2020
21 CFR 211.68(b)

Computer control of master formula records

Cited by Christopher R Czajka

Inspected site

NLNOVA LABORATORIES LIMITEDWigston, United Kingdom

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.67(c)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere